Patients with depression typically exhibit dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis, elevated concentrations of adrenocorticotropic hormone (ACTH) and cortisol, increased production of inflammatory factors, and upregulation of osteoclast activity, ultimately resulting in aberrant bone metabolism (36). The gene discussed is POMC; the disease is depressive symptom measurement.